Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48


Serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease.

Kim H, Lee EJ, Kim S, Choi LK, Kim K, Kim HW, Kim KK, Lim YM.

Neurol Neuroimmunol Neuroinflamm. 2020 Mar 17;7(3). pii: e708. doi: 10.1212/NXI.0000000000000708. Print 2020 May.


Benefit of Targeting a LDL (Low-Density Lipoprotein) Cholesterol <70 mg/dL During 5 Years After Ischemic Stroke.

Amarenco P, Kim JS, Labreuche J, Charles H, Giroud M, Lee BC, Mahagne MH, Nighoghossian N, Gabriel Steg P, Vicaut É, Bruckert E; Treat Stroke to Target Investigators.

Stroke. 2020 Apr;51(4):1231-1239. doi: 10.1161/STROKEAHA.119.028718. Epub 2020 Feb 20.


Changes in High-Density Lipoprotein Cholesterol and Risks of Cardiovascular Events: A Post Hoc Analysis from the PICASSO Trial.

Lee EJ, Kwon SU, Park JH, Kim YJ, Hong KS, Yu S, Hwang YH, Lee JS, Lee J, Rha JH, Heo SH, Ahn SH, Seo WK, Park JM, Lee JH, Kwon JH, Sohn SI, Jung JM, Kim HY, Kim EG, Kim SH, Cha JK, Park MS, Nam HS, Kang DW; PICASSO Investigators.

J Stroke. 2020 Jan;22(1):108-118. doi: 10.5853/jos.2019.02551. Epub 2020 Jan 31.


Depressive Symptoms in Stroke Patients: Are There Sex Differences?

Lee EJ, Kim JS, Chang DI, Park JH, Ahn SH, Cha JK, Heo JH, Sohn SI, Lee BC, Kim DE, Kim HY, Kim S, Kwon DY, Kim J, Seo WK, Lee J, Park SW, Koh SH, Kim JY, Choi-Kwon S.

Cerebrovasc Dis. 2020;49(1):19-25. doi: 10.1159/000506116. Epub 2020 Feb 5.


Machine Learning Approach to Identify Stroke Within 4.5 Hours.

Lee H, Lee EJ, Ham S, Lee HB, Lee JS, Kwon SU, Kim JS, Kim N, Kang DW.

Stroke. 2020 Mar;51(3):860-866. doi: 10.1161/STROKEAHA.119.027611. Epub 2020 Jan 28.


Neuro-Ophthalmologic Features and Outcomes of Thalamic Infarction: A Single-Institutional 10-Year Experience.

Moon Y, Eah KS, Lee EJ, Kang DW, Kwon SU, Kim JS, Lim HT.

J Neuroophthalmol. 2019 Dec 16. doi: 10.1097/WNO.0000000000000864. [Epub ahead of print]


A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke.

Amarenco P, Kim JS, Labreuche J, Charles H, Abtan J, Béjot Y, Cabrejo L, Cha JK, Ducrocq G, Giroud M, Guidoux C, Hobeanu C, Kim YJ, Lapergue B, Lavallée PC, Lee BC, Lee KB, Leys D, Mahagne MH, Meseguer E, Nighoghossian N, Pico F, Samson Y, Sibon I, Steg PG, Sung SM, Touboul PJ, Touzé E, Varenne O, Vicaut É, Yelles N, Bruckert E; Treat Stroke to Target Investigators.

N Engl J Med. 2020 Jan 2;382(1):9. doi: 10.1056/NEJMoa1910355. Epub 2019 Nov 18.


Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study.

Kim JS, Lee KB, Park JH, Sung SM, Oh K, Kim EG, Chang DI, Hwang YH, Lee EJ, Kim WK, Ju C, Kim BS, Ryu JM; SAFE-TPA Investigators.

Ann Neurol. 2020 Feb;87(2):233-245. doi: 10.1002/ana.25644. Epub 2019 Nov 29.


Post-stroke cognitive impairment as an independent predictor of ischemic stroke recurrence: PICASSO sub-study.

Kwon HS, Lee D, Lee MH, Yu S, Lim JS, Yu KH, Oh MS, Lee JS, Hong KS, Lee EJ, Kang DW, Kwon SU; PICASSO investigators.

J Neurol. 2020 Mar;267(3):688-693. doi: 10.1007/s00415-019-09630-4. Epub 2019 Nov 12.


Intra-arterial thrombectomy for acute ischaemic stroke patients with active cancer.

Lee D, Lee DH, Suh DC, Kwon HS, Jeong DE, Kim JG, Lee JS, Kim JS, Kang DW, Jeon SB, Lee EJ, Noh KC, Kwon SU.

J Neurol. 2019 Sep;266(9):2286-2293. doi: 10.1007/s00415-019-09416-8. Epub 2019 Jun 7.


NGL-3 in the regulation of brain development, Akt/GSK3b signaling, long-term depression, and locomotive and cognitive behaviors.

Lee H, Shin W, Kim K, Lee S, Lee EJ, Kim J, Kweon H, Lee E, Park H, Kang M, Yang E, Kim H, Kim E.

PLoS Biol. 2019 Jun 5;17(6):e2005326. doi: 10.1371/journal.pbio.2005326. eCollection 2019 Jun.


Pupillary dysfunction of multiple system atrophy: Dynamic pupillometric findings and clinical correlations.

Park KW, Choi N, Ryu HS, Kim MS, Lee EJ, Chung SJ.

Parkinsonism Relat Disord. 2019 Aug;65:234-237. doi: 10.1016/j.parkreldis.2019.05.003. Epub 2019 May 5.


Efficacy and safety of alemtuzumab in Korean multiple sclerosis patients.

Kim H, Lee EJ, Kim SK, Kim KK, Lim YM.

Mult Scler Relat Disord. 2019 May;30:247-251. doi: 10.1016/j.msard.2019.03.001. Epub 2019 Mar 2.


The clinical and prognostic value of antinuclear antibodies in NMO-IgG seropositive neuromyelitis optica spectrum disorder.

Lee EJ, Lim YM, Kim SY, Lee J, Kim H, Jin JY, Oh YJ, Kim KK.

J Neuroimmunol. 2019 Mar 15;328:1-4. doi: 10.1016/j.jneuroim.2018.11.012. Epub 2018 Nov 28.


Comparison of brain magnetic resonance imaging between myotonic dystrophy type 1 and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Kim H, Lim YM, Oh YJ, Lee EJ, Kim KK.

PLoS One. 2018 Dec 6;13(12):e0208620. doi: 10.1371/journal.pone.0208620. eCollection 2018.


The Impact of Cerebral Atherosclerosis According to Location on Prognosis after Coronary Artery Bypass Grafting.

Lee EJ, Chung CH, Choi KH, Lee JW, Choo SJ, Jung SH, Kang DW, Kim JS, Kwon SU.

Cerebrovasc Dis. 2018;46(5-6):200-209. doi: 10.1159/000494502. Epub 2018 Nov 8.


The effects of the elastin polymorphisms on carotid intima-media thickness in women aged 30 - 70.

Lim ST, Park JK, Park SH, Lee EJ, Kim WN, Min SK.

J Exerc Nutrition Biochem. 2018 Jun 30;22(2):18-22. doi: 10.20463/jenb.2018.0012.


Factors predicting remission in thymectomized patients with acetylcholine receptor antibody-positive myasthenia gravis.

Kim H, Lim YM, Lee EJ, Oh YJ, Kim KK.

Muscle Nerve. 2018 Dec;58(6):796-800. doi: 10.1002/mus.26300. Epub 2018 Nov 8.


Differences in Therapeutic Responses and Factors Affecting Post-Stroke Depression at a Later Stage According to Baseline Depression.

Lee EJ, Kim JS, Chang DI, Park JH, Ahn SH, Cha JK, Heo JH, Sohn SI, Lee BC, Kim DE, Kim HY, Kim S, Kwon DY, Kim J, Seo WK, Lee J, Park SW, Koh SH, Kim JY, Choi-Kwon S, Kim MS, Lee JS; EMOTION Investigators.

J Stroke. 2018 May;20(2):258-267. doi: 10.5853/jos.2017.02712. Epub 2018 May 31.

Supplemental Content

Loading ...
Support Center